Dosage Forms

Articles

The agency is taking steps to monitor the supply chain and assist in the development of treatments.

FDA Responds to Coronavirus Outbreak

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

The research community is moving quickly to launch clinical trials of potential countermeasures, while regulatory authorities aim to support product development through regulatory flexibility. 

Coronavirus Offers Opportunities and Challenges for Biopharma R&D

The vaccine is designed to provide active immunity against the influenza A (H5N1) strain and can be easily deployed in a pandemic event.

FDA Approves Seqirus’ Adjuvanted, Cell-Based Pandemic Influenza Vaccine

J&J’s Janssen Pharmaceutical Companies seeks to develop a vaccine candidate against the novel coronavirus. 

Johnson & Johnson to Develop a Vaccine Candidate Against Novel Coronavirus

FDA has granted fast track designation for Novavax’s NanoFlu, a recombinant quadrivalent flu vaccine, for use by adults age 65 years and older.

Novavax Granted Fast Track Designation for NanoFlu in Older Adults

Sanofi Pasteur will expand clinical development and manufacturing of an adjuvanted recombinant pandemic vaccine at its site in Pennsylvania.

Sanofi Expands Pandemic Flu Vaccine Manufacturing

CPI has partnered with ImmunoBiology (ImmBio) for the development of a heat-stabilized formulation of a mutli-antigen vaccine candidate against Pneumococcal diseases.

CPI Partners with ImmunoBiology for Heat-Stabilized Formulation of Pneumococcal Vaccine

Countries and partners have announced commitments to vaccinate 450 million children against polio each year and overcome barriers to reaching all children.

Global Leaders Pledge $2.6 Billion to Eradicate Polio

The plant in Singen, Germany will be used for formulation, filling, and packaging of Takeda’s vaccine candidate.

Takeda Opens Dengue Vaccine Plant in Germany

Scientists from the University of Texas Medical Branch in Galveston and Profectus BioSciences of New York have developed the candidate quadrivalent VesiculoVax vaccine, an investigational vaccine that protected monkeys against four types of hemorrhagic fever viruses endemic to overlapping regions in Africa.

Vaccines